Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Real-World Evidence (RWE): The need for a multi-stakeholder approach
|
Aug 18, 2023 |
Rare Reflections: Impact of the OMP revision on rare disease companies in Europe
|
Jul 11, 2023 |
MDR/IVDR: Recent changes and their implications for EU medical device companies
|
Apr 10, 2023 |
Trans-Atlantic Innovation : Building bridges between the EU and US life sciences industry
|
Mar 13, 2023 |
Rare Disease Day 2023: Improving equitable access and diagnosis for people living with a rare disease
|
Feb 22, 2023 |
The new EU HTA Procedure: Getting it right to improve patients' access to innovative therapies
|
Jan 30, 2023 |
2022 Year in Review: Perspectives & Resolutions from the EUCOPE Policy Team
|
Dec 21, 2022 |
Launch Conditionality: The Impact on Small and Mid-Sized Companies
|
Dec 16, 2022 |
Advanced Therapy Medicinal Products (ATMPs): How they will be affected by the General Pharmaceutical Legislation
|
Oct 13, 2022 |
Ensuring a robust European Health Data Space (EHDS): Working to create a fit-for-purpose regulatory framework
|
Sep 19, 2022 |
Unmet Medical Needs (UMN): Towards a new understanding with a focus on underserved areas
|
Jul 18, 2022 |
Overcoming Barriers: Improving Access for Rare Disease Patients through Cross-Border Healthcare
|
Jun 06, 2022 |
Increasing Access to Genomic Testing in Europe: The role of national genomics initiatives in increasing uptake of Advanced Diagnostics
|
May 10, 2022 |
What's next for EU Rare Disease Legislation? Its potential implications for patients and pharma entrepreneurs
|
Feb 21, 2022 |
The European Pharmaceutical Strategy: A patient-centred and future-proof framework?
|
Sep 23, 2021 |
Fostering an EU Advanced Diagnostics Ecosystem
|
May 27, 2021 |
A Future-proof HTA System in Europe?
|
Apr 21, 2021 |
Sounds of Science - Trailer
|
Apr 07, 2021 |